Fibromyaljisi Olan Diabetes Mellitus Hastaları Yüksek Kardiovasküler Hastalık Riskine Sahipler

Abstract

Aim: The primary aim of this study is to investigate the effect of the presence of Fibromyalgia(FM) on cardiovascular risk and cardiopulmonary capacity in diabetes mellitus (DM) patients. In addition, the prevalence of FM in DM patients was investigated according to the American College of Rheumatology (ACR) 2016 criteria.
 Material and Methods: The study included 188 premenopausal female patients with Type 2 DM. The physical activity level of the study participants was assessed with the International Physical Activity Questionnaire - short form. The cardiopulmonary capacity was evaluated with the 6-minute Walk Test. The cardiovascular risks were evaluated with the Framingham risk score. Participants were examined for the presence of FM according to the ACR 2016 criteria.
 Results: 63 (33.5%) participants met the ACR 2016 FM diagnostic criteria. DM patients with FM have significantly lower physical activity levels (p=0.004) and cardiopulmonary capacity (p=0.009), and they also have significantly higher cardiovascular risks (p=0.02) than DM patients without FM. 
 Conclusion: FM is seen in approximately one-third of DM patients, and the presence of FM reduces cardiopulmonary capacity and increases cardiovascular risk. In the management of patients diagnosed with DM, the presence of FM should be investigated, and treatment should be applied with pharmacological and non-pharmacological methods to reduce the contribution to cardiovascular risk.